002393 深市 力生制药

天津力生制药股份有限公司
 2024 年半年度财务报告

    2024 年 8 月 23 日

一、审计报告
半年度报告是否经过审计
□是  否
公司半年度财务报告未经审计。
二、财务报表
财务附注中报表的单位为：元
1、合并资产负债表

                          编制单位：天津力生制药股份有限公司

                                    2024 年 06 月 30 日

                                                                                                单位：元

              项目                            期末余额                          期初余额

流动资产：

  货币资金                                          1,597,539,990.01                    1,988,965,076.50

  结算备付金

  拆出资金

  交易性金融资产                                      431,665,067.90                    160,544,456.79

  衍生金融资产

  应收票据                                              42,440,741.38                      73,025,653.35

  应收账款                                            290,908,870.13                      44,727,806.48

  应收款项融资                                          81,062,576.04                    194,759,687.37

  预付款项                                              46,593,389.93                      12,687,193.12
……